Antibodies to ribosomes in chronic active hepatitis.

PubWeight™: 12.78‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 758135)

Published in Gastroenterology on January 01, 1979


M A Gerber, J M Shapiro, H Smith, O Lebwohl, F Schaffner

Articles by these authors

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med (1978) 15.13

General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ (1998) 13.39

Safety and effectiveness of nurse telephone consultation in out of hours primary care: randomised controlled trial. The South Wiltshire Out of Hours Project (SWOOP) Group. BMJ (1998) 10.82

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10

Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53

Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97

A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63

Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med (2000) 5.68

Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78

Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77

Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ (2010) 4.53

Publication bias and clinical trials. Control Clin Trials (1987) 4.34

Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ (1999) 4.03

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74

MR imaging and T2 mapping of femoral cartilage: in vivo determination of the magic angle effect. AJR Am J Roentgenol (2001) 3.69

A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65

Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48

Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol (2006) 3.34

Future provision of out of hours primary medical care: a survey with two general practitioner research networks. BMJ (1996) 3.34

Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 3.33

Paediatric intensive care transfers. Anaesthesia (2000) 3.32

Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ (1999) 3.16

Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med (1983) 3.04

Appropriateness of use of emergency ambulances. J Accid Emerg Med (1998) 3.02

Rate of regeneration of peripheral nerves in man. J Physiol (1943) 3.02

Transgene-mediated auxin overproduction in Arabidopsis: hypocotyl elongation phenotype and interactions with the hy6-1 hypocotyl elongation and axr1 auxin-resistant mutants. Plant Mol Biol (1995) 3.01

Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96

Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90

Is perinatal mortality still a good indicator of perinatal care? Paediatr Perinat Epidemiol (1988) 2.87

Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61

Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (1992) 2.61

In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med (1990) 2.61

A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59

Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54

Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48

Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ (2010) 2.46

Derivatives of 6-aminopenicillanic acid. XI. Alpha-amino-p-hydroxybenzylpenicillin. J Chem Soc Perkin 1 (1971) 2.39

Genetic engineering of harvest index in tobacco through overexpression of a phytochrome gene. Nat Biotechnol (1996) 2.36

Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36

Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33

Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32

Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32

Phytochrome and photomorphogenesis in plants. Nature (1970) 2.26

Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19

Earthquake injuries related to housing in a guatemalan village. Science (1977) 2.18

Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16

Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract (1997) 2.15

Biochemical challenge of microbial pathogenicity. Bacteriol Rev (1968) 2.14

Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene (2007) 2.14

Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09

The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05

The ultrastructure of acidophilic "Councilman-like" bodies in the liver. Am J Pathol (1966) 2.04

Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ (2010) 2.03

Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (1988) 1.98

Hepatitis after exposure to halothane. Ann Intern Med (1969) 1.95

Groin hernia repair in Scotland. Br J Surg (2000) 1.93

The aetiological agent of cat scratch disease. Lancet (1985) 1.93

Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89

Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88

Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo. J Gen Microbiol (1977) 1.85

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85

Anthrax toxic complex. Fed Proc (1967) 1.84

Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84

A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83

Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog (1988) 1.81

Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med (1992) 1.80

Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog (1989) 1.80

Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79

Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut (1979) 1.78

Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74

Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73

ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol (1997) 1.72

Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol (1988) 1.72

Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest (1986) 1.71

Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol (1974) 1.70

1% or less: a community-based nutrition campaign. Public Health Rep (1998) 1.69

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet (1991) 1.67

Fatty liver hepatitis and cirrhosis in obese patients. Am J Med (1979) 1.66

Hydrogenated oils and fats: the presence of chemically-modified fatty acids in human adipose tissue. Am J Clin Nutr (1981) 1.65

Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol (1973) 1.65

Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63

Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res (1998) 1.63

Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61

Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60

Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59

Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate. Arch Ophthalmol (1980) 1.59

Genome differences among varicella-zoster virus isolates. J Gen Virol (1983) 1.59

Factors affecting the induction of phenotypically determined serum resistance of Neisseria gonorrhoeae grown in media containing serum or its diffusible components. J Gen Microbiol (1981) 1.58

Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med (1989) 1.57

Penicillin neurotoxicity. Ann N Y Acad Sci (1967) 1.57

Latex agglutination tests for rapid identification of group A streptococci directly from throat swabs. J Pediatr (1984) 1.56

Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology (1988) 1.55

Fat-storing cells (lipocytes) in human liver. Arch Pathol (1966) 1.55